BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 27753426)

  • 21. Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice.
    Shi L; Nikolic D; Liu S; Lu H; Wang S
    Am J Physiol Renal Physiol; 2009 Feb; 296(2):F257-65. PubMed ID: 19004931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet.
    Wang Y; Xie BQ; Gao WH; Yan DY; Zheng WL; Lv YB; Cao YM; Hu JW; Yuan ZY; Mu JJ
    Kidney Blood Press Res; 2015; 40(6):605-13. PubMed ID: 26619289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
    J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal protective effects of blocking the intrarenal renin-angiotensin system.
    Li J; Zhou C; Yu L; Wang H
    Hypertens Res; 1999 Sep; 22(3):223-8. PubMed ID: 10515446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
    Loghman-Adham M; Soto CE; Inagami T; Cassis L
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria.
    Takase O; Marumo T; Imai N; Hirahashi J; Takayanagi A; Hishikawa K; Hayashi M; Shimizu N; Fujita T; Saruta T
    Kidney Int; 2005 Aug; 68(2):464-73. PubMed ID: 16014023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
    Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renoprotective and antihypertensive effect of combination therapy with a low protein diet, long-term exercise and angiotensin II receptor antagonist in rats with renal ablation].
    Sasaki Y; Kanazawa M; Ito O; Kohzuki M
    Nihon Jinzo Gakkai Shi; 2006; 48(1):4-13. PubMed ID: 16480061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of Central (Pro)renin Receptor Ameliorates Salt-Induced Renal Injury in Chronic Kidney Disease.
    Li J; Liang M; Zeng T; Qiu M; Zhang M; Jiang S; Tan L; Li A
    Antioxid Redox Signal; 2021 Jul; 35(2):93-112. PubMed ID: 32757619
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of intrarenal renin-angiotensin system during metabolic acidosis.
    Ng HY; Chen HC; Tsai YC; Yang YK; Lee CT
    Am J Nephrol; 2011; 34(1):55-63. PubMed ID: 21659740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
    Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
    PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
    Teplan V; Schück O; Votruba M; Poledne R; Kazdová L; Skibová J; Malý J
    Wien Klin Wochenschr; 2001 Sep; 113(17-18):661-9. PubMed ID: 11603100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
    Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis.
    Gilbert RE; Wu LL; Kelly DJ; Cox A; Wilkinson-Berka JL; Johnston CI; Cooper ME
    Am J Pathol; 1999 Aug; 155(2):429-40. PubMed ID: 10433936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease.
    Bellizzi V; Calella P; Hernández JN; González VF; Lira SM; Torraca S; Arronte RU; Cirillo P; Minutolo R; Montúfar Cárdenas RA
    BMC Nephrol; 2018 May; 19(1):110. PubMed ID: 29743031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
    Goto M; Hoxha N; Osman R; Dell KM
    Pediatr Nephrol; 2010 Dec; 25(12):2449-57. PubMed ID: 20798958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
    Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
    Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of low-protein diet supplemented with ketoacids and erythropoietin in chronic renal failure: a long-term metabolic study.
    Teplan V; Schück O; Knotek A; Hajný J; Horácková M; Skibová J; Malý J
    Ann Transplant; 2001; 6(1):47-53. PubMed ID: 11803607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.